Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Complete pathologic response is independent of the timing of esophagectomy following neoadjuvant chemoradiation for esophageal cancer.
Journal: Journal of gastrointestinal oncology
Published: March 23, 2018
Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: December 28, 2015
Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
Journal: JAMA surgery
Published: April 23, 2015
Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer.
Journal: Surgical endoscopy
Published: May 01, 2013
Neoadjuvant chemoradiotherapy for esophageal/gastroesophageal carcinoma.
Journal: Journal of gastrointestinal oncology
Published: January 24, 2013
Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus.
Journal: Lasers in surgery and medicine
Published: November 08, 2011
Showing 1-6 of 6
Last Updated: 09/26/2026